Progresión en glaucoma. Guía de práctica clínica
- Laia Jaumandreu 16
- Alfonso Antón 256
- Marta Pazos 36
- Ignacio Rodriguez-Una 67
- Iñaki Rodriguez Agirretxe 68
- José María Martínez-De-La-Casa 69
- Miriam Eleonora Ayala 26
- M. Parrilla-Vallejo 46
- Agnieszka Anna Dyrda 2
- Laura Díez-Álvarez 16
- Gema Rebolleda 16
- Francisco José Muñoz-Negrete 16
-
1
Hospital Ramón y Cajal
info
- 2 Institut Català de la Retina (ICR), Barcelona, España
-
3
Hospital Clinic Barcelona
info
-
4
Hospital Universitario Virgen Macarena
info
-
5
Universitat Internacional de Catalunya
info
-
6
Instituto de Salud Carlos III
info
-
7
Universidad de Oviedo
info
-
8
Hospital Universitario de Donostia
info
-
9
Hospital Clínico San Carlos de Madrid
info
ISSN: 0365-6691
Année de publication: 2023
Volumen: 98
Número: 1
Pages: 40-57
Type: Article
D'autres publications dans: Archivos de la Sociedad Española de Oftalmologia
Résumé
Objective To provide general recommendations that serve as a guide for the evaluation and management of glaucomatous progression in daily clinical practice based on the existing quality of clinical evidence. Methods After defining the objectives and scope of the guide, the working group was formed and structured clinical questions were formulated following the PICO (Patient, Intervention, Comparison, Outcomes) format. Once all the existing clinical evidence had been independently evaluated with the AMSTAR 2 (Assessment of Multiple Systematic Reviews) and Cochrane «Risk of bias» tools by at least two reviewers, recommendations were formulated following the Scottish Intercollegiate Guideline network (SIGN) methodology. Results Recommendations with their corresponding levels of evidence that may be useful in the interpretation and decision-making related to the different methods for the detection of glaucomatous progression are presented. Conclusions Despite the fact that for many of the questions the level of scientific evidence available is not very high, this clinical practice guideline offers an updated review of the different existing aspects related to the evaluation and management of glaucomatous progression.